• Print
  • Sign up for E-news
  • RSS Feeds
Marty Glick
Chief Financial Officer

Marty Glick is in his first season as the chief financial officer for the Golden State Warriors, having been named to the position on June 27, 2011. In his role as CFO and minority owner, Glick oversees all financial strategy, planning and accounting for the organization.

A highly-regarded former biotech executive whose affiliations have a history of innovative success, Glick has accumulated a wealth of experience as a prominent financial figure for several large biotech businesses during his career. He spent more than a decade (1987- 1997) at Genentech of South San Francisco, where he most recently served as vice president of finance. He also served as executive vice president and chief financial officer of Theravance, a Bay Area-based drug discovery company, for seven years (1998-2005) and was a co-founder and board member of Eyetech Pharmaceuticals.

Additionally, Glick was co-founder and chairman of the board of PEAK Surgical – an innovative private medical device company – and his résumé also includes a seven-plus year stint as the chair of the Biotech Tax and Finance Committee.

A native of Chicago, Illinois, Glick earned his MBA in Finance at Kellogg School of Management (Northwestern University), his BSBA in Accounting at Creighton University and is also a CPA and Chartered Accountant (Ontario, Canada).
You do not have the correct version of the Flash Player Plugin. Click here to get it.